Comparative study of gp130 cytokine effects on corticotroph AtT-20 cells - Redundancy or specificity of neuroimmunoendocrine modulators?

NeuroImmunoModulation

Volumn 11, Issue 4, 2004, Pages 224-232

  Auernhammer, Christoph J ^a,d   Kopp, Florian B ^a   Vlotides, George ^a   Dorn, Franziska ^a   Isele, Nicola B ^a   Spöttl, Gerald ^a   Cengic, Neziha ^a   Weber, Matthias M ^b   Senaldi, Giorgio ^c   Engelhardt, Dieter ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c AMGEN INC   (United States)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

ACTH; Corticotroph AtT 20; gp130 cytokines; POMC; SOCS; STAT

Indexed keywords

B CELL STIMULATING FACTOR 3; CARDIOTROPHIN 1; CILIARY NEUROTROPHIC FACTOR; CILIARY NEUROTROPHIC FACTOR RECEPTOR; CORTICOTROPIN; CYTOKINE; GLYCOPROTEIN GP 130; INTERLEUKIN 11; INTERLEUKIN 4; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; LEUKEMIA INHIBITORY FACTOR RECEPTOR; ONCOSTATIN M; STAT1 PROTEIN; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING; SUPPRESSOR OF CYTOKINE SIGNALING 3; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL FUNCTION; CELL LINE; CONTROLLED STUDY; CORTICOTROPIN RELEASE; GENE EXPRESSION; IMMUNOMODULATION; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; ANTIGENS, CD; CELL LINE; CYTOKINE RECEPTOR GP130; CYTOKINES; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LEUKEMIA INHIBITORY FACTOR RECEPTOR ALPHA SUBUNIT; LIGANDS; MEMBRANE GLYCOPROTEINS; MICE; NEUROIMMUNOMODULATION; PHOSPHORYLATION; PITUITARY GLAND, ANTERIOR; PRO-OPIOMELANOCORTIN; PROMOTER REGIONS (GENETICS); RECEPTOR, CILIARY NEUROTROPHIC FACTOR; RECEPTORS, CYTOKINE; RECEPTORS, OSM-LIF; REPRESSOR PROTEINS; RNA, MESSENGER; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TYROSINE;

EID: 3142664732     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000078440     Document Type: Article

References (43)

1. Heinrich PC, Behrmann I, Müller-Newen G, Schaper F, Graeve L: Interleukin-6-type cytokine signaling through the gp130/Jak/STAT pathway. Biochem J 1998;334:297-314.
2. Auernhammer CJ, Melmed S: Leukemia-inhibitory factor-neuroimmune modulator of endocrine function (review). Endocr Rev 2000;21:313-345.
3. Arzt E: gp130 cytokine signaling in the pituitary gland: A paradigm for cytokine-neuroendocrine pathways (review). J Clin Invest 2001;108:1729-1733.
4. Melmed S: Series introduction: The immuno-neuroendocrine interface (review). J Clin Invest 2001;108:1563-1566.
5. Chesnokova V, Melmed S: Minireview: Neuro-immuno-endocrine modulation of the hypothalamic-pituitary-adrenal (HPA) axis by gp130 signaling molecules. Endocrinology 2002;143:1571-1574.
6. Auernhammer CJ, Melmed S: The central role of SOCS-3 in integrating the neuroimmunoendocrine interface (review). J Clin Invest 2001;108:1735-1740.
7. Akita S, Webster J, Ren SG, Takino H, Said J, Zand O, Melmed S: Human and murine pituitary expression of leukemia inhibitory factor. Novel intrapituitary regulation of adrenocorticotropin hormone synthesis and secretion. J Clin Invest 1995;95:1288-1298.
8. Ray DW, Ren SG, Melmed S: Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line. Role of STAT pathway. J Clin Invest 1996;97:1852-1859.
9. Stefana B, Ray DW, Melmed S: Leukemia inhibitory factor induces differentiation of pituitary corticotroph function: An immuno-neuroendocrine phenotypic switch. Proc Natl Acad Sci USA 1996;93:12502-12506.
10. Shimon I, Yan X, Ray DW, Melmed S: Cytokine-dependent gp130 receptor subunit regulates human fetal pituitary adrenocorticotropin hormone and growth hormone secretion. J Clin Invest 1997;100:357-363.
11. Kim DS, Choi HS, Park YS, Kim TW: Effects of oncostatin M on hormone release of rat pituitary cells in primary culture. J Korean Med Sci 2000;15:323-326.
12. Auernhammer CJ, Isele NB, Kopp FB, Spoettl G, Cengic N, Weber MM, Senaldi G, Engelhardt D: Novel neurotrophin-1/B-cell stimulating factor-3 (cardiotrophin-like cytokine) stimulates corticotroph function via a signal transducer and activator of transcription-dependent mechanism negatively regulated by suppressor of cytokine signaling-3. Endocrinology 2003;144:1202-1210.
13. Woloski BM, Smith EM, Meyer WJ 3rd, Fuller GM, Blalock JE: Corticotropin-releasing activity of monokines. Science 1985;230:1035-1037.
14. Fukata J, Usui T, Naitoh Y, Nakai Y, Imura H: Effects of recombinant human interleukin-1α, -1β, 2 and 6 on ACTH synthesis and release in the mouse pituitary tumour cell line AtT-20. J Endocrinol 1989;122:33-39.
15. Katahira M, Iwasaki Y, Aoki Y, Oiso Y, Saito H: Cytokine regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. Endocrinology 1998;139:2414-2422.
16. Li QL, Jansen E, Friedman TC: Regulation of prohormone convertase 1 (PC1) by gp130-related cytokines. Mol Cell Endocrinol 1999;158:143-152.
17. Auernhammer CJ, Melmed S: Interleukin-11 stimulates proopiomelanocortin gene expression and adrenocorticotropin secretion in corticotroph cells: Evidence for a redundant cytokine network in the hypothalamo-pituitary-adrenal axis. Endocrinology 1999;140:1559-1566.
18. Senaldi G, Varnum BC, Sarmiento U, Starnes C, Lile J, Scully S, Guo J, Elliott G, McNinch J, Shaklee CL, Freeman D, Manu F, Simonet WS, Boone T, Chang MS: Novel neurotrophin-1/B cell-stimulating factor-3: A cytokine of the IL-6 family. Proc Natl Acad Sci USA 1999;96:11458-11463.
19. Shi Y, Wang W, Yourey PA, Gohari S, Zukauskas D, Zhang J, Ruben S, Alderson RF: Computational EST database analysis identifies a novel member of the neuropoietic cytokine family. Biochem Biophys Res Commun 1999;262:132-138.
20. Elson GC, Lelievre E, Guillet C, Chevalier S, Plun-Favreau H, Froger J, Suard I, de Coignac AB, Delneste Y, Bonnefoy JY, Gauchat JF, Gascan H: CLF associates with CLC to form a functional heteromeric ligand for the CNTF receptor complex. Nat Neurosci 2000;3:867-872.
21. Plun-Favreau H, Elson G, Chabbert M, Froger J, deLapeyriere O, Lelievre E, Guillet C, Hermann J, Gauchat JF, Gascan H, Chevalier S: The ciliary neurotrophic factor receptor alpha component induces the secretion of and is required for functional responses to cardiotrophin-like cytokine. EMBO J 2001;20:1692-1703.
22. Lelievre E, Plun-Favreau H, Chevalier S, Froger J, Guillet C, Elson GC, Gauchat JF, Gascan H: Signaling pathways recruited by the cardiotrophin-like cytokine/cytokine-like factor-1 composite cytokine: Specific requirement of the membrane-bound form of ciliary neurotrophic factor receptor α component. J Biol Chem 2001;276:22476-22484.
23. Hanisch A, Dieterich KD, Dietzmann K, Ludecke K, Buchfelder M, Fahlbusch R, Lehnert H: Expression of members of the interleukin-6 family of cytokines and their receptors in human pituitary and pituitary adenomas. J Clin Endocrinol Metab 2000;85:4411-4414.
24. Pereda MP, Lohrer P, Kovalovsky D, Perez Castro C, Goldberg V, Losa M, Chervin A, Berner S, Molina H, Stalla GK, Renner U, Arzt E: Interleukin-6 is inhibited by glucocorticoids and stimulates ACTH secretion and POMC expression in human corticotroph pituitary adenomas. Exp Clin Endocrinol Diabetes 2000;108:202-207.
25. Bethin KE, Vogt SK, Muglia LJ: Interleukin-6 is an essential, corticotropin-releasing hormone-independent stimulator of the adrenal axis during immune system activation. Proc Natl Acad Sci USA 2000;97:9317-9322.
26. Auernhammer CJ, Bousquet C, Melmed S: Autoregulation of pituitary corticotroph SOCS-3 expression: Characterization of the murine SOCS-3 promoter. Proc Natl Acad Sci USA 1999;96:6964-6969.
27. Chikanza IC, Petrou P, Chrousos G: Perturbations of arginine vasopressin secretion during inflammatory stress. Pathophysiologic implications (review). Ann NY Acad Sci 2000;917:825-834.
28. Mulchahey JJ, Regmi A, Sheriff S, Balasubramaniam A, Kasckow JW: Coordinate and divergent regulation of corticotropin-releasing factor (CRF) and CRF-binding protein expression in an immortalized amygdalar neuronal cell line. Endocrinology 1999;140:251-259.
29. Path G, Scherbaum WA, Bornstein SR: The role of interleukin-6 in the human adrenal gland (review). Eur J Clin Invest 2000;30(suppl 3):91-95.
30. Franchimont D, Bouma G, Galon J, Wolkersdorfer GW, Haidan A, Chrousos GP, Bornstein SR: Adrenal cortical activation in murine colitis. Gastroenterology 2000;119:1560-1568.
31. Auernhammer CJ, Chesnokova V, Bousquet C, Melmed S: Pituitary corticotroph SOCS-3: Novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion. Mol Endocrinol 1998;12:954-961.
32. Malik N, Kallestad JC, Gunderson NL, Austin SD, Neubauer MG, Ochs V, Marquardt H, Zarling JM, Shoyab M, Wei CM: Molecular cloning, sequence analysis, and functional expression of a novel growth regulator, oncostatin M. Mol Cell Biol 1989;9:2847-2853.
33. Yoshimura A, Ichihara M, Kinjyo I, Moriyama M, Copeland NG, Gilbert DJ, Jenkins NA, Hara T, Miyajima A: Mouse oncostatin M: An immediate early gene induced by multiple cytokines through the JAK-STAT5 pathway. EMBO J 1996;15:1055-1063.
34. Lindberg RA, Juan TS, Welcher AA, Sun Y, Cupples R, Guthrie B, Fletcher FA: Cloning and characterization of a specific receptor for mouse oncostatin M. Mol Cell Biol 1998;18:3357-3367.
35. Tanaka M, Hara T, Copeland NG, Gilbert DJ, Jenkins NA, Miyajima A: Reconstitution of the functional mouse oncostatin M (OSM) receptor: Molecular cloning of the mouse OSM receptor beta subunit. Blood 1999;93:804-815.
36. Wang Y, Robledo O, Kinzie E, Blanchard F, Richards C, Miyajima A, Baumann H: Receptor subunit-specific action of oncostatin M in hepatic cells and its modulation by leukemia inhibitory factor. J Biol Chem 2000;275:25273-25285.
37. Auernhammer CJ, Dorn F, Dietrich A, Engelhardt D, Weber MM: Murine oncostatin M stimulates corticosterone secretion in murine adrenocortical Y-1 cells (abstract). Exp Clin Endocrinol Diabetes 2001;109(suppl 1):S19.
38. Latchman DS: Cardiotrophin-1: A novel cytokine and its effects in the heart and other tissues (review). Pharmacol Ther 2000;85:29-37.
39. Robledo O, Fourcin M, Chevalier S, Guillet C, Auguste P, Pouplard-Barthelaix A, Pennica D, Gascan H: Signaling of the cardiotrophin-1 receptor. Evidence for a third receptor component. J Biol Chem 1997;21;272:4855-4863.
40. Benigni F, Fantuzzi G, Sacco S, Sironi M, Pozzi P, Dinarello CA, Sipe JD, Poli V, Cappelletti M, Paonessa G, Pennica D, Panayotatos N, Ghezzi P: Six different cytokines that share GP130 as a receptor subunit, induce serum amyloid A and potentiate the induction of interleukin-6 and the activation of the hypothalamus-pituitary-adrenal axis by interleukin-1. Blood 1996;87:1851-1854.
41. Talwar S, Squire IB, Downie PF, O'Brien RJ, Davies JE, Ng LL: Elevated circulating cardiotrophin-1 in heart failure: Relationship with parameters of left ventricular systolic dysfunction. Clin Sci (Lond) 2000;99:83-88.
42. Ng LL, O'Brien RJ, Demme B, Jennings S: Non-competitive immunochemiluminometric assay for cardiotrophin-1 detects elevated plasma levels in human heart failure. Clin Sci (Lond) 2002;102:411-416.
43. Anker SD, Ponikowski PP, Clark AL, Leyva F, Rauchhaus M, Kemp M, Teixeira MM, Hellewell PG, Hooper J, Poole-Wilson PA, Coats AJ: Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure. Eur Heart J 1999;20:683-693.